We’re reading about drug pricing deals, a new cancer therapy approval, and more Meanwhile, BioNTech has terminated a Phase 2 trial for its colon cancer vaccine

https://www.statnews.com/pharmalot/2026/08/31/drug-pricing-deals-polycythemia-vera-mimrylo-pharmalittle-newsletter/ By Jason MastAug. 31, 2026 General Assignment Reporter